Skip to main content
AmigoFish

Rheumnow Podcast

Dr. CushAudio

Format:
Podcast
New episodes:
Daily
Typical length:
about 20 minutes
Latest episode:
Not rated yet

About this show

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

Covers: rheumatology, rheumatoid arthritis, lupus, interstitial lung disease, medical research, biologic drugs, autoimmune disease, car-t therapy

Show details and episodes come from the publisher's public feed at feed.podbean.com. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent episodes, drawn from the publisher's feed.

This podcast, hosted by Dr. Jack Cush, walks through rheumatology news, journal studies and regulatory decisions from the past week. Recent episodes cover ACR 2026 topics, including JAK inhibitor safety in rheumatoid arthritis, CAR-T therapy for lupus nephritis, and GLP-1 drugs and lung health.

Report a problem with this summary

Cosmos

Similar by topic and creator

See the full Cosmos

Similar shows

See all Health shows

Explore more

Episodes

  • ACR 2026 RheumNow RA Topic Compilation c

    · 38 min

    Lifestyle Interventions and Biological Effects in RA First theranostic approach to treat difficult-to-treat RA Biologics after Cancer Is it Safe RA-ILD and Lung Cancer Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression Infliximab Biosimilar Switching Anti-CCP Antibody Testing on the Spot

    Not rated yet
  • ACR 2026 RheumNow RA Topic Compilation b

    · 36 min

    JAKi Cardiovascular Safety in Younger Adults Four Joint Fibromyalgia Warning Difficult to Treat RA Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease Good News and Bad News for CCP+ at Risk for RA Combination Therapy in Rheumatoid Arthritis Snippets & SNPs in ILD and Fibrosis CAR-T in Rheumatoid Arthritis will it stay Not Seronegative Rheumatoid Arthritis-Interstitial Lung Disease What Happens to Muscle Mass and Muscle Strength in RA

    Not rated yet
  • ACR 2026 RheumNow RA Topic Compilation a

    · 32 min

    Can a smartphone identify inflammatory arthritis GLP-1 A game changer for lung health Menopause in RA An Under Recognized Burden JAK vs TNFi in RA Can Biomarkers Help us Choose JAK1 TYK2i beats Tofacitinib in Active RA Rosnilimab in RA Why May it be Relatively Safe Can Gut Candida Trigger Rheumatoid Arthritis Maybe Head to Head JAK vs JAK in RA Fibromyalgia and Depression in Rheumatoid Arthritis A New Way to Measure Disease Activity in Rheumatoid Arthritis Study Design and Comparative Effectiveness in RA GLP-1 Drugs in Osteoarthritis and Rheumatoid Arthritis

    Not rated yet
  • ACR 2026: RA Topic Panel

    · 31 min

    What stood out in rheumatoid arthritis at ACR 2026? Join Drs. Jon Kay, Jack Cush and Artie Kavanaugh for RheumNow’s RA Topic Panel Recap. They discuss the research that caught their attention in Orlando and what the findings could mean for the everyday care of patients with RA.

    Not rated yet
  • ACR 2026 RheumNow Lupus Topic Compilation d

    · 22 min

    The InVivo Wave Hype or Hope 5mg kg HCQ Threshold in SLE Is it Time to Reconsider Lessons learned from ReBioLup data in Lupus Nephritis

    Not rated yet
  • ACR 2026 RheumNow Lupus Topic Compilation c

    · 22 min

    Kidney Transplantation in Lupus Treating joints and weight together TOGETHER PSA Belimumab and Rituximab for SLE A Successful Trial Silent Drifts Non adherence and inflammation in SLE Drugs in Lupus Nephritis Save Kidney Function, Increase Survival Three Factors Shape Vaccine Response in Immune-Mediated Inflammatory Disease

    Not rated yet
  • ACR 2026 RheumNow Lupus Topic Compilation b

    · 18 min

    Lupus Control without Steroid Burden The Lupus Outcomes Gap Block the Antibody Lupus, Myositis, Scleroderma Proteinuria Another one bites the dust in lupus nephritis Tirzepitide Add on or start together in PsA Does the Air we Breathe Shape Lupus

    Not rated yet
  • ACR 2026 RheumNow Lupus Topic Compilation a

    · 19 min

    Statins and eGFR in SLE Long-term Opioid Use in Lupus Does Obesity Play a Role Two targets or one CAR-T in Lupus Nephritis Hydroxychloroquine Blood Levels and Retinopathy Risk When Low Cardiovascular Risk Misses Coronary Plaque Low PREVENT Score, Real Risk Coronary Calcium and Heart Failure in Lupus SGLT2 Inhibitors in Lupus Nephritis Lupus Remission is not one Single Thing

    Not rated yet
  • ACR 2026 RheumNow ILD Topic Compilation c

    · 21 min

    Real World of SARD ILD What are our goals, really, in ILD RA-ILD and Lung Cancer Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression

    Not rated yet
  • ACR 2026 RheumNow ILD Topic Compilation b

    · 14 min

    Does Scl-Ab change predict pulmonary decline in systemic sclerosis Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease Snippets & SNPs in ILD and Fibrosis Interstitial Pneumonia with Autoimmune Features (IPAF)

    Not rated yet
  • ACR 2026 RheumNow ILD Topic Compilation a

    · 13 min

    New Treatments in ILD Mortality and Myositis in ILD Screen-detected ILD in Scleroderma Can we do Pulmonary Testing at Home VALORous Efforts in Dermatomyositis Interstitial Lung Disease

    Not rated yet
  • ACR 2026 RheumNow CAR T Topic Compilation

    · 25 min

    Two targets or one CAR-T in Lupus Nephritis New Rheumatic Disease after CAR-T New Treatments in Scleroderma Early Days CAR T Without Lymphodepletion CAR-T in Rheumatoid Arthritis will it stay Preliminary PK, PD, Clinical and Safety Data of NK019 in Myositis The InVivo Wave Hype or Hope

    Not rated yet
  • ACR 2026 RheumNow Fibromyalgia Topic Compilation c

    · 11 min

    Nociplastic Pain in axSpA Myositis Hurts

    Not rated yet
  • ACR 2026 RheumNow Fibromyalgia Topic Compilation b

    · 7 min

    UPSTAND study widespread pain responding to JAK inhibition Who Manages Fibromyalgia

    Not rated yet
  • ACR 2026 RheumNow Fibromyalgia Topic Compilation a

    · 9 min

    New Therapy for Fibromyalgia Pain in axSpA may Reflect More than Inflammation Fibromyalgia and Depression in Rheumatoid Arthritis Four Joint Fibromyalgia Warning

    Not rated yet
  • ACR 2026 RheumNow Obesity Topic Compilation c

    · 17 min

    GLP-1 Drugs in Osteoarthritis and Rheumatoid Arthritis Treating joints and weight together TOGETHER PSA GLP-1 Agonists in Psoriatic Arthritis GLP-1s and Obesity in Rheumatic Disease

    Not rated yet
  • ACR 2026 RheumNow Obesity Topic Compilation b

    · 12 min

    Retatrutide for knee osteoarthritis and obesity One dose for every body Rethinking drug exposure Tirzepitide Add on or start together in PsA Can GLP-1 Therapy Help PsA Beyond Losing Weight

    Not rated yet
  • ACR 2026 RheumNow Obesity Topic Compilation a

    · 10 min

    Long-term Opioid Use in Lupus Does Obesity Play a Role GLP-1 A game changer for lung health TRIUMPH-4 Retatrutide GLP-1 in Osteoarthritis Incidence of Obesity Overweight in PsA Four in Five

    Not rated yet
  • ACR 2026 RheumNow PsA Topic Compilation c

    · 14 min

    GLP-1 Agonists in Psoriatic Arthritis TNFi Failure in PsA to cycle or not cycle Biologics vs JAKi MACE and VTE Risk in PsA

    Not rated yet
  • ACR 2026 RheumNow PsA Topic Compilation b

    · 22 min

    BE BOLD Bimekizumab beats Risankizumab in PsA GLP-1s and Obesity in Rheumatic Disease BE BOLD with Professor McInnes

    Not rated yet